What does BIOCARE do?

BIOCARE is registered with the CBE as active in: Vervaardiging van parfums en toiletartikelen. Private Limited, started on 24 January 2017, 1 establishment.

What is the address of BIOCARE?

The registered office of BIOCARE is located at Rue de la Berwinne 17, 4450 Juprelle.

Is BIOCARE still active?

Yes. According to the CBE (30 October 2026) BIOCARE is active, legal situation “Normale toestand”, started on 24 January 2017.

Is BIOCARE registered on Peppol?

Yes, BIOCARE is registered on the Peppol network with ID 0208:0669941683.

What is the enterprise number of BIOCARE?

The enterprise number of BIOCARE is BE0669941683.

When was BIOCARE founded?

BIOCARE was founded on 24 January 2017.

Who are the directors of BIOCARE?

According to the 2024 annual accounts, the directors of BIOCARE are: Franck GRANDJEAN.

Is BIOCARE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 January 2017; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did BIOCARE make in 2024?

BIOCARE recorded a loss after taxes of € 1,104 in financial year 2024.

What is the revenue of BIOCARE?

As a small company, BIOCARE is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 281,914.

BIOCARE (Private Limited) - Juprelle - BE0669941683

Dossier BIOCARE, printed on 30 October 2026 from databakkes.be/en/0669941683/biocare. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Late annual account NBB

Fiscal year 2024 was filed 281 days after the legal deadline.

Financials

Financial year 2024

BIOCARE from Juprelle, company number BE0669941683, closed financial year 2024 with a result of € -1,104 after tax. For that financial year BIOCARE recorded a gross margin of € 281,914 and equity of € 279,068. Compared with financial year 2023, the result moved from € 62,866 to € -1,104. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 8, 2026.

What it is worth Healthy

€ 279,068

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -1,104

▼ still € 62,866 profit in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 12,515

▲ € 10,467 vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 196,316.

People and assets in 2024

Wage cost

€ 81,179

▲ 7% vs 2023

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 842,713

▼ 4% vs 2023

Of which on lease € 838,502.

Debts at end 2024

Bank debt ≈ 16 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.7 million

▲ 5% vs 2023

€ 90,550 is repaid this year. At this pace the long-term loan is gone in ≈ 16 years.

Owed to suppliers

€ 104,301

▲ 18% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 42,240

▲ 18% vs 2023

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 174,781 Gross margin 2021: € 174,781 First fiscal year in the series	€ 231,013 Gross margin 2022: € 231,013 ▲ 32% vs 2021 (€ 174,781) Favourable step	€ 229,812 Gross margin 2023: € 229,812 ▼ 1% vs 2022 (€ 231,013) Unfavourable step	€ 281,914 Gross margin 2024: € 281,914 ▲ 23% vs 2023 (€ 229,812) Favourable step	▲ 23%
Profit after taxes	€ 28,464 Profit after taxes 2021: € 28,464 First fiscal year in the series	€ 3,141 Profit after taxes 2022: € 3,141 ▼ 89% vs 2021 (€ 28,464) Unfavourable step	€ 62,866 Profit after taxes 2023: € 62,866 ▲ € 59,724 vs 2022 (€ 3,141) Favourable step	€ -1,104 Profit after taxes 2024: € -1,104 ▼ € 63,970 vs 2023 (€ 62,866) Unfavourable step	▼ € 63,970
Equity	€ 213,682 Equity 2021: € 213,682 First fiscal year in the series	€ 222,865 Equity 2022: € 222,865 ▲ 4% vs 2021 (€ 213,682) Favourable step	€ 280,173 Equity 2023: € 280,173 ▲ 26% vs 2022 (€ 222,865) Favourable step	€ 279,068 Equity 2024: € 279,068 Unchanged (€ 280,173) Unfavourable step
Total debts	€ 817,214 Total debts 2021: € 817,214 First fiscal year in the series	€ 994,377 Total debts 2022: € 994,377 ▲ 22% vs 2021 (€ 817,214) Unfavourable step	€ 1,813,307 Total debts 2023: € 1,813,307 ▲ 82% vs 2022 (€ 994,377) Unfavourable step	€ 1,844,003 Total debts 2024: € 1,844,003 ▲ 2% vs 2023 (€ 1,813,307) Unfavourable step	▲ 2%
Cash	€ 7 Cash 2021: € 7 First fiscal year in the series	€ 15,249 Cash 2022: € 15,249 ▲ € 15,241 vs 2021 (€ 7) Favourable step	€ 2,048 Cash 2023: € 2,048 ▼ 87% vs 2022 (€ 15,249) Unfavourable step	€ 12,515 Cash 2024: € 12,515 ▲ € 10,467 vs 2023 (€ 2,048) Favourable step	▲ € 10,467
Land & buildings	€ 643,820 Land & buildings 2021: € 643,820 First fiscal year in the series	€ 642,844 Land & buildings 2022: € 642,844 Unchanged (€ 643,820) Unchanged	€ 616,975 Land & buildings 2023: € 616,975 ▼ 4% vs 2022 (€ 642,844) Unchanged	€ 577,159 Land & buildings 2024: € 577,159 ▼ 6% vs 2023 (€ 616,975) Unchanged	▼ 6%
Retained profit	€ 131,414 Retained profit 2021: € 131,414 First fiscal year in the series	€ 134,555 Retained profit 2022: € 134,555 ▲ 2% vs 2021 (€ 131,414) Favourable step	€ 197,421 Retained profit 2023: € 197,421 ▲ 47% vs 2022 (€ 134,555) Favourable step	€ 196,316 Retained profit 2024: € 196,316 ▼ 1% vs 2023 (€ 197,421) Unfavourable step	▼ 1%
Dividend	€ 200,000 Dividend 2021: € 200,000 First fiscal year in the series	€ 0 Dividend 2022: € 0 ▼ 100% vs 2021 (€ 200,000) Unchanged	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 521,409 Bank debt 2021: € 521,409 First fiscal year in the series	€ 783,378 Bank debt 2022: € 783,378 ▲ 50% vs 2021 (€ 521,409) Unfavourable step	€ 1,603,575 Bank debt 2023: € 1,603,575 ▲ 105% vs 2022 (€ 783,378) Unfavourable step	€ 1,677,012 Bank debt 2024: € 1,677,012 ▲ 5% vs 2023 (€ 1,603,575) Unfavourable step	▲ 5%
Balance sheet total	€ 1,030,896 Balance sheet total 2021: € 1,030,896 First fiscal year in the series	€ 1,217,242 Balance sheet total 2022: € 1,217,242 ▲ 18% vs 2021 (€ 1,030,896) Unchanged	€ 2,093,480 Balance sheet total 2023: € 2,093,480 ▲ 72% vs 2022 (€ 1,217,242) Unchanged	€ 2,123,071 Balance sheet total 2024: € 2,123,071 ▲ 1% vs 2023 (€ 2,093,480) Unchanged	▲ 1%

Key figures of BIOCARE, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to BIOCARE?

What happened at BIOCARE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 8, 2026 New annual accounts for financial year 2024: loss of € 1,104 (▼ € 63,970 vs 2023). filed late Source: NBB ↗
Feb 7, 2017 New establishment in Juprelle. KBO
Jan 24, 2017 Start of the company according to the CBE. KBO

In short

From € 28,464 profit in 2021 to € 1,104 loss in 2024.

Paid € 4,290 in corporate taxes since 2021.

Best year ever: 2023, with € 62,866 profit.

Paid out € 200,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Franck GRANDJEAN

BIOCARE

LES LABORATOIRES FAMA

G.L.D.

Behind BIOCARE is Franck GRANDJEAN. Franck GRANDJEAN is also behind LES LABORATOIRES FAMA and G.L.D..

Directors

According to the 2024 annual accounts

Franck GRANDJEAN

Director

Also active at: LES LABORATOIRES FAMA, G.L.D.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Berwinne 17

4450 Juprelle

2.260.990.420

Rue de la Berwinne 12

4450 Juprelle

Active since 7 February 2017

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Biocare Academie

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0669.941.683
VAT number: BE 0669.941.683
Registered office: Rue de la Berwinne 17, 4450 Juprelle
Names & denominations: BIOCARE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 January 2017
Peppol: Active · Active since 1 Sept 2026
Activities · NACE: Vervaardiging van parfums en toiletartikelen

View on CBE Public ↗ Annual accounts (NBB) ↗